The three ABT-737 sensitive cell lines were chosen as they represent an array of DLBCL phenotypes based on predominant anti-apoptotic BCL-2 family member expression (e.g. BCL-2, BCL-XL, and MCL-1). This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.